Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1471
|
42
|
0.100 |
None |
1.000 |
11 |
|
1992 |
2019 |
fibrinogen activity
|
phenotype |
|
Molecular Function
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Fibrinogen, CTCAE
|
phenotype |
|
Finding
|
26
|
63
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Fibrinogen assay
|
phenotype |
|
Laboratory Procedure
|
55
|
143
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Increased level of L-fucose in urine
|
phenotype |
|
Finding
|
14
|
|
0.100 |
None |
|
0 |
|
|
|
Bronchioloalveolar Adenocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
136
|
5
|
0.100 |
None |
|
0 |
|
|
|
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.090 |
None |
0.889 |
9 |
|
2012 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.090 |
None |
1.000 |
9 |
|
1998 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.080 |
None |
1.000 |
8 |
|
1998 |
2018 |
Hepatitis C
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1768
|
347
|
0.070 |
None |
1.000 |
7 |
|
2003 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.070 |
None |
1.000 |
7 |
|
2002 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.070 |
None |
1.000 |
7 |
|
2003 |
2015 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.070 |
None |
1.000 |
7 |
|
2002 |
2018 |
Tuberculosis
|
disease |
Infections
|
Disease or Syndrome
|
1256
|
328
|
0.060 |
None |
1.000 |
6 |
|
2002 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2015 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.060 |
None |
1.000 |
6 |
|
1993 |
2000 |
cervical cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1817
|
268
|
0.050 |
None |
1.000 |
5 |
|
2004 |
2015 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.050 |
None |
1.000 |
5 |
|
2012 |
2019 |
Infection
|
group |
Infections
|
Pathologic Function
|
491
|
|
0.050 |
None |
1.000 |
5 |
|
2002 |
2008 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.050 |
None |
0.800 |
5 |
|
2000 |
2019 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.050 |
None |
1.000 |
5 |
|
2000 |
2014 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.050 |
None |
1.000 |
5 |
|
2010 |
2019 |
Myelodysplasia
|
disease |
|
Congenital Abnormality
|
181
|
4
|
0.050 |
None |
1.000 |
5 |
|
1993 |
1999 |